StonvexLoading…
StonvexStonvexStonvexCore line items from FOXA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $12.91B | $8.92B | $3.74B | $16.30B |
Operating Income | $1.36B | $1.12B | $799.00M | $3.06B |
Net Income | $1.03B | $856.00M | $609.00M | $2.29B |
EPS (Diluted) | $2.24 | $1.85 | $1.32 | $4.91 |
Total Assets | $21.78B | $21.47B | $22.77B | $23.20B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $3.60B | $2.02B | $4.37B | $5.35B |
Free Cash Flow OCF − CapEx | $742.00M | $-1.02B | $-234.00M | $2.99B |
Shares Outstanding | 443.00M | 448.00M | 455.00M | 461.00M |